Company Filing History:
1 out of 35 
1 out of 7 Years Active: 2018
Title: Maho Yamaguchi: Innovator in Prostate Health Diagnostics
Introduction
Maho Yamaguchi is a notable inventor hailing from Shizuoka, Japan, with a significant contribution to the field of medical diagnostics. With one patent to his name, Yamaguchi has developed a method that improves the precision of distinguishing between prostate carcinoma and benign prostatic hyperplasia, thereby impacting patient care.
Latest Patents
Yamaguchi's patent, titled "Method and kit for distinguishing between prostate carcinoma and benign prostatic hyperplasia," outlines a sophisticated technique that utilizes prostate-specific antigen (PSA) analysis. This method involves bringing a sample containing PSA into contact with a carrier that has an anti-free PSA antibody immobilized on it. The process allows for the specific binding and measurement of free PSA types, helping to determine prostate health more accurately. The comparisons made with preset cutoff values enable healthcare professionals to assess the likelihood of prostate carcinoma or benign prostatic hyperplasia effectively.
Career Highlights
Throughout his career, Maho Yamaguchi has collaborated with prestigious institutions such as Hirosaki University and Shizuoka Prefectural University Corporation. His work has been integral in advancing the understanding of prostate health and enhancing diagnostic capabilities for related diseases.
Collaborations
In his research endeavors, Yamaguchi has worked alongside colleagues, including Chikara Ohyama and Tohru Yoneyama. Their collaborative efforts have contributed significantly to the development of medical diagnostics, ensuring that patient outcomes improve through innovative techniques.
Conclusion
Maho Yamaguchi’s inventive work in developing a method for distinguishing prostate diseases stands as a testament to his dedication to medical innovation. His contributions not only reflect his expertise as an inventor but also signify an advancement in the fight against prostate-related health issues, showcasing the importance of continued research and teamwork in the realm of medical diagnostics.